Phase One • Two Countries • Three Clinics
Nucleus Network is Australia’s largest Phase 1 clinical research organization and the only Phase 1 specialist globally with facilities in the USA and Australia. Since our establishment in 2004, Nucleus Network has conducted well over 1000 Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe, including China, Europe, Japan, South Korea, Taiwan and the USA.
Our Australian Phase 1 facilities are in Melbourne and Brisbane, and our USA Phase 1 facility is in Minneapolis. Combined, our clinics offer over 200 beds. All three clinics are strategically co-located within leading medical, research and biotech precincts; the Alfred Hospital in Melbourne, the Royal Brisbane and Women’s Hospital in Brisbane, and Medical Alley in Minnesota.
These precincts provide Nucleus Network with unique access to highly specialized ancillary services for the conduct of complex Phase 1 clinical trials. From specialist PD equipment for first in human studies in Melbourne, purpose-built infrastructure for high volume biosimilar studies in Brisbane, and onsite dialysis capabilities for complicated renal studies in Minneapolis, Nucleus Network has the experience to conduct the most complex early phase clinical trials.
Together with our clients, we are fulfilling our purpose of "Advancing medicine, improving lives."
Australia offers one of the fastest regulatory approval processes in world where an IND is required to be opened prior to commencing first in human clinical trials.
Clinical trial data generated in Australia (including first in human clinical trial data) is acceptable to the USA FDA, EMA, PMDA and Health Canada Regulatory Bodies.
Foreign currency exchange makes Australia up to 20%-30% cheaper than the USA. There is also potential to access Australia’s Research and Development (R&D) Tax Scheme, where eligible companies can access a 43.5% cash refund.
Long-term partnerships with private clinicians and speciality groups for conducting early phase patient clinical trials, including access to moderate and severely impaired hepatic and renal patients.
Strategically located in the Medical Alley Biotech and Life sciences epicenter of Minnesota and between the Twin Cities (St. Paul / Minneapolis).
Access to patients for either standalone or combined umbrella clinical trial protocols of healthy volunteers and patient populations.